Lenalidomide Capsules 15 Mg – Generic Revlimid

Lenalidomide Capsules 15 Mg – Generic Revlimid

Lenalidomide Capsules 15 Mg – Generic Revlimid is an immunomodulatory anticancer medication used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain lymphomas. It works by enhancing the immune system, inhibiting tumor growth, and blocking the formation of blood vessels that support cancer progression. This dosage strength is commonly prescribed as part of individualized treatment regimens based on patient response and tolerability. In therapy planning, lower doses such as Lenalidomide Capsules 10 Mg – Generic Revlimid may be used initially or for dose adjustments, while higher strengths like Lenalidomide Capsules 25 Mg – Generic Revlimid are often considered in more intensive treatment protocols.

Mechanism of Action

Immunomodulatory Activity

Lenalidomide Capsules 15 Mg stimulates immune cells such as T-cells and natural killer (NK) cells, enhancing the body’s ability to attack cancer cells.

Anti-Angiogenic Effect

It inhibits angiogenesis, preventing tumors from developing new blood vessels required for growth and survival.

Direct Anticancer Action

The medication directly interferes with cancer cell proliferation, leading to reduced tumor progression. For detailed research insights, refer to National Cancer Institute (NCI) and for safety information, consult Mayo Clinic – Lenalidomide Drug Information.

Medical Uses

Lenalidomide Capsules 15 Mg – Generic Revlimid is used in:

• Multiple myeloma
• Myelodysplastic syndromes (MDS)
• Mantle cell lymphoma

It is often used in combination with corticosteroids or other anticancer agents to improve treatment outcomes.

Dosage and Administration

Lenalidomide Capsules 15 Mg is typically taken once daily in cycles, as prescribed by an oncologist. The dosage depends on the patient’s condition, response, and tolerance. In treatment adjustments, Lenalidomide Capsules 10 Mg – Generic Revlimid may be used for dose reduction, while escalation to Lenalidomide Capsules 25 Mg – Generic Revlimid may be considered based on therapeutic response and clinical requirements.

Clinical Effectiveness

Clinical studies have demonstrated that Lenalidomide significantly improves progression-free survival and response rates in patients with multiple myeloma and related conditions. It is a key drug in modern hematologic oncology treatment protocols.

Safety and Side Effects

Common Side Effects

• Fatigue
• Diarrhea or constipation
• Rash
• Low blood cell counts

Serious Risks

• Blood clots (deep vein thrombosis)
• Severe neutropenia and infection risk
• Birth defects (teratogenic risk)

Regular blood monitoring is essential during treatment. For more details, refer to Mayo Clinic – Lenalidomide Drug Information.

Contraindications and Precautions

Lenalidomide Capsules 15 Mg should not be used in:

• Pregnancy (high risk of severe birth defects)
• Patients with hypersensitivity to lenalidomide

Strict pregnancy prevention measures must be followed during therapy.

Drug Interactions

Lenalidomide Capsules 15 Mg may interact with anticoagulants, other anticancer medications, and drugs affecting immune function. Patients should inform their healthcare provider about all medications they are taking. For research-based insights, refer to National Cancer Institute (NCI).

FAQs